Cited by 201Tryptophan and brain disordersTreatment of Major DepressionStress Responses and Cortisol

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy

Capuron, Lucile, Ravaud, Alain, Gualde, Norbert, Bosmans, Eugene, Dantzer, Robert, Maes, Michael, Neveu, Pierre J·2001·Psychoneuroendocrinology

Abstract

The relationship between immune activation and the development of early depressive symptoms were studied in 33 cancer patients undergoing cytokine therapy. Patients were treated either with subcutaneous IL-2 administered alone (n=13) or in association with IFN-alpha (n=5), or with IFN-alpha alone administered subcutaneously at low doses (n=5) or intravenously at high doses (n=10). The intensity of depressive symptoms was assessed during a clinical interview carried out before the start of cytokine therapy and five days later using the Montgomery and Asberg Depression Rating Scale (MADRS). On the same days, blood samples were collected for each patient to measure serum concentrations of cytokines (IL-6, IL-10, IL-1ra) and cytokine-receptors (sIL-2R, LIF-R). Results showed that patients treated with IL-2 or IL-2+IFN-alpha displayed concomitant mood symptoms and increased serum cytokine levels during treatment. In these patients, the intensity of depressive symptoms at endpoint was positively correlated with the increases measured in serum levels of IL-10 between baseline and endpoint. IL-10 is an anti-inflammatory cytokine that is produced in response to the production of pro-inflammatory cytokines, and thereby reflects an inflammatory response. These results support the hypothesis of close relationship between depressive symptoms and the activation of the cytokine network.

Integrity signals

Registry

Crossref · 10.1016/s0306-4530(01)00030-0

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J.
Affiliations
  • Inserm (FR)
  • Centre National de la Recherche Scientifique (FR)
  • Maastricht University Medical Centre (NL)
Corresponding author
Capuron, Lucile
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2001-11
Volume
26
Issue
8
Pages
797-808
ISSN
0306-4530 (ISSN-L)
OpenAlex
W2047987784
Cited by
201
References
35
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 9 · 2019: 2 · 2018: 12 · 2017: 6 · 2016: 10 · 2015: 13 · 2014: 9 · 2013: 7 · 2012: 5
FWCI
3.21
Type
journal article
Language
en
Open access
closed
Locations
  • Psychoneuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
immune activation, depressive symptoms, cancer patients, interleukin-2, interferon-alpha, cytokine therapy, IL-10, serum cytokines, soluble interleukin-2 receptor, inflammation, mood disorders
MeSH terms
Affect, Aged, Carcinoma, Renal Cell, Depression, Female, Humans, Immunity, Interleukin-2, Kidney Neoplasms, Male, Middle Aged, Cytokines, Interferon-alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review